| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 06/14/2001 | WO2001042299A2 Hepatitis virus sentinel virus i (svi) |
| 06/14/2001 | WO2001041801A2 Mutant simplex virus for treating unwanted hyperproliferative cell growth |
| 06/14/2001 | US20010003650 Fusion proteins capapble of presenting the peptide in a conformationally restricted form; use in screening peptide libraries |
| 06/14/2001 | CA2394052A1 In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps) |
| 06/14/2001 | CA2393644A1 Hepatitis virus sentinel virus i (svi) |
| 06/14/2001 | CA2393454A1 Infection of eukaryotic cells with viruses in vitro |
| 06/14/2001 | CA2393045A1 Mutant er.alpha. and test systems for transactivation |
| 06/14/2001 | CA2362685A1 Use of recombinant parainfluenza viruses (pivs) as vectors to protect against infection and disease caused by piv and other human pathogens |
| 06/13/2001 | EP1106692A1 Rna virus vector having contact infiltration capability |
| 06/13/2001 | EP1105506A1 Adenoviral vectors encoding erythropoietin and their use in gene therapy |
| 06/13/2001 | EP1105498A1 Hiv vaccine |
| 06/13/2001 | EP1105497A1 Cold-adapted equine influenza viruses |
| 06/13/2001 | EP1105495A2 Method for producing yeast expressed hpv types 6 and 16 capsid proteins |
| 06/13/2001 | EP1105470A1 USE OF SUPPRESSOR tRNA'S TO REGULATE CYTOTOXICITY DURING THE PRODUCTION OF RECOMBINANT GENE PRODUCTS |
| 06/13/2001 | EP1105466A1 Process for purifying human papillomavirus virus-like particles |
| 06/13/2001 | EP1105157A1 Protein delivery system using human papillomavirus virus-like particles |
| 06/13/2001 | CN1298947A Virus with specigic reproduction in tumor well and effective expression of tumor angiogenesis inhibitor and its construction method |
| 06/12/2001 | US6245549 Culturing virus from paramyxoviridae family in media free of exogenous serum proteins, isolating virus, solubilizing envelope glycoproteins; using affinity chromotography to isolate/purify immunogenic envelope glycoproteins; infants |
| 06/12/2001 | US6245504 Transducing phages of Actinomycetales |
| 06/12/2001 | US6245330 Recombinant adenoviruses coding for glial-derived neurotrophic factor (GDNF) |
| 06/07/2001 | WO2001040455A2 Compositions and methods for increasing packaging and yields of recombinant adenoviruses using multiple packaging signals |
| 06/07/2001 | WO2001040448A1 Methods for removal, purification, and concentration of viruses, and methods of therapy based thereupon |
| 06/07/2001 | WO2001040447A1 Hiv-1 protease inhibitor resistance assay |
| 06/07/2001 | WO2001040443A2 Method for producing adherent animal cells |
| 06/07/2001 | WO2001039802A1 Chimeric flavivirus vaccines |
| 06/07/2001 | WO2001039801A2 Safe attenuated bovine viral diarrhea viruses for use in pregnant cows |
| 06/07/2001 | WO2001039797A2 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 06/07/2001 | DE19955558A1 Permanente Amniozyten-Zelllinie, ihre Herstellung und Verwendung zur Herstellung von Gentransfervektoren Permanent amniocytic cell line, their preparation and use for producing gene transfer vectors |
| 06/07/2001 | CA2393325A1 Infectious clones |
| 06/07/2001 | CA2392762A1 Method for producing adherent animal cells |
| 06/07/2001 | CA2392537A1 Compositions and methods for increasing packaging and yields of recombinant adenoviruses using multiple packaging signals |
| 06/07/2001 | CA2388678A1 Safe attenuated bovine viral diarrhea viruses for use in pregnant cows |
| 06/06/2001 | EP1104676A1 Safe attenuated bovine viral diarrhea viruses for use in pregnant cows |
| 06/06/2001 | EP1104482A2 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins |
| 06/05/2001 | US6242250 Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions |
| 06/05/2001 | US6242239 Process for separating HIV from a fluid |
| 06/05/2001 | US6241991 Aviadenovirus |
| 06/05/2001 | US6241990 Immunogenic composition containing inactivated swine infertility and respiratory Syndrome virus |
| 06/05/2001 | US6241982 Method for treating brain cancer with a conditionally lethal gene |
| 06/05/2001 | CA1341245C Recombinant vaccinia virus mva |
| 06/05/2001 | CA1341242C Dna sequence, vectors, recombinant viruses, and process involving recombinant cowpox viruses capable of multiplying in cho cells |
| 06/05/2001 | CA1341241C Expression of a tumor-specific antigen through a recombinant virus vector, and its use for prevention or cure of the corresponding tumor |
| 05/31/2001 | WO2001038548A2 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 05/31/2001 | WO2001038537A1 Method of constructing cell-fusion type morbillivirus mutant |
| 05/31/2001 | WO2001038499A1 Membrane virus host range mutations and their uses as vaccine substrates |
| 05/31/2001 | WO2001038498A2 A new genotype of hepatitis b virus |
| 05/31/2001 | WO2001038497A1 Duck pneumovirus and corresponding vaccines |
| 05/31/2001 | WO2001038362A2 Production of vaccines |
| 05/31/2001 | WO2001038361A1 Modified adenovirus fibre and uses |
| 05/31/2001 | WO2001038358A2 Hbv/hcv virus-like particle |
| 05/31/2001 | WO2001037867A1 A new defective adenovirus and process for producing said adenovirus |
| 05/31/2001 | WO2001037656A2 Preservation of sensitive biological material |
| 05/31/2001 | WO2000002524A3 Botulinum neurotoxin vaccine |
| 05/31/2001 | WO2000000617A3 Ebola virion proteins expressed from venezuelan equine encephalitis (vee) virus replicons |
| 05/31/2001 | CA2392527A1 Hbv/hcv virus-like particle |
| 05/31/2001 | CA2392272A1 Modified adenovirus fibre and uses |
| 05/31/2001 | CA2392235A1 Membrane virus host range mutations and their uses as vaccine substrates |
| 05/31/2001 | CA2391379A1 Preservation of sensitive biological material |
| 05/31/2001 | CA2389667A1 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 05/30/2001 | EP1103615A1 Vectors capable of immortalizing non-dividing cells and cells immortalized with said vectors |
| 05/30/2001 | EP1103610A1 Production of vaccines from immortalised mammalian cell lines |
| 05/30/2001 | EP1102992A1 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis c virus protease |
| 05/30/2001 | EP1102858A2 Cell lines for the propagation of mutated herpes viruses |
| 05/30/2001 | EP1102790A2 Immunological herpes simplex virus antigens and methods for use thereof |
| 05/30/2001 | EP1102788A2 Prevention and treatment of viral disease |
| 05/30/2001 | CN1297486A Anti-viral vectors |
| 05/30/2001 | CN1297479A Modified adenovirus contg. fiber replacement protein |
| 05/30/2001 | CN1297478A Compositions comprising viruses and methods for concentrating virus preparations |
| 05/30/2001 | CN1297043A Chinese bollworm virogenic engineering strain No.1 |
| 05/29/2001 | US6238893 Method for intracellular DNA amplification |
| 05/29/2001 | US6238859 Virus protein antigens of the JC virus |
| 05/29/2001 | US6238858 Producing secondary virus such as togavirus or retrovirus in producer host cell for subsequent infection of target cells by using chimeric primary virus or combination which direct production in the host cells; gene therapy |
| 05/29/2001 | US6238669 Proteins encoded by chicken anemia virus DNA and diagnostic kits and vaccines employing said proteins |
| 05/25/2001 | WO2001036651A1 Preparation of human or animal herpesviruses |
| 05/25/2001 | WO2001036615A2 Permanent amniocyte cell line, the production thereof and its use for producing gene transfer vectors |
| 05/25/2001 | WO2001036601A1 Method for the preparation of purified hcv rna by exosome separation |
| 05/25/2001 | WO2001035970A1 Viruses for the treatment of cellular proliferative disorders |
| 05/25/2001 | WO2001035733A1 Method of acquiring immunological tolerance |
| 05/25/2001 | WO2000070024A3 Infectious retroviruses from a leukemic dog cell line with extensive homologies to murine leukemia viruses |
| 05/25/2001 | CA2720361A1 Viruses for the treatment of cellular proliferative disorders |
| 05/25/2001 | CA2388807A1 Viruses for the treatment of cellular proliferative disorders |
| 05/24/2001 | US20010001709 Methods for enhancing the production of viral vaccines in cell culture |
| 05/24/2001 | US20010001661 Gene delivery in various muscle cell types; gene therapy for expression of erythropoietin to treat blood disorders such as anemias, for example |
| 05/23/2001 | EP1100946A1 Vectors derived from baculovirus and use for transferring nucleic acids into nerve cells of vertebrates |
| 05/23/2001 | EP1100945A2 Latency-active regulatory sequences of herpesviruses and lantency-inactive herpesviruses for gene transfer |
| 05/23/2001 | EP1100944A1 Targeted alphavirus and alphaviral vectors |
| 05/23/2001 | EP1100942A2 Herpes virus vectors for dendritic cells |
| 05/23/2001 | EP1100934A1 Herpesvirus preparations and their uses |
| 05/23/2001 | EP1100925A1 Attenuated equine herpesvirus |
| 05/23/2001 | EP1100916A2 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal |
| 05/23/2001 | EP1100890A2 Improved transformation efficiency in phage display through modification of a coat protein |
| 05/23/2001 | EP1100545A1 Regulated expression of recombinant proteins using rna viruses |
| 05/23/2001 | EP1100533A2 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof |
| 05/22/2001 | US6235881 Polypeptides encoded by novel HIV-2 proviruses |
| 05/22/2001 | US6235525 Nucleotide sequence; diagnosis; vaccines; transfected cell line |
| 05/22/2001 | US6235522 Lentiviral vectors |
| 05/22/2001 | US6235521 Phage bonded to a nuclear location signal |
| 05/22/2001 | US6235469 Generation of transcriptional sequences associated with phage envelope protein; incubate and insert nucleotide sequences into expression vector, express gene coded in vector and recover polypeptides |
| 05/22/2001 | US6235278 Biological insect control agents expressing insect-specific toxin genes, methods and compositions |
| 05/17/2001 | WO2001023577A3 Hybrid or chimeric polynucleotides, proteins, and compositions comprising hepatitis b virus sequences |